Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005;7(3):186-96.
doi: 10.1080/13651820510028954.

Liver cell adenoma and liver cell adenomatosis

Ludger Barthelmes  1 , Iain S Tait
Affiliations

Liver cell adenoma and liver cell adenomatosis

Ludger Barthelmes et al. HPB (Oxford). 2005.

Abstract

During the last three decades liver cell adenoma and liver cell adenomatosis have emerged as new clinical entities in hepato-logical practice due to the widespread use of oral contraceptives and increased imaging of the liver. On review of published series there is evidence that 10% of liver cell adenomas progress to hepatocellular carcinoma, diagnosis is best made by open or laparoscopic excision biopsy, and the preferred treatment modality is resection of the liver cell adenoma to prevent bleeding and malignant transformation. In liver cell adenomatosis, the association with oral contraceptive use is not as high as in solitary liver cell adenomas. The risk of malignant transformation is not increased compared with solitary liver cell adenomas. Treatment consists of close monitoring and imaging, resection of superficially located, large (>4 cm) or growing liver cell adenomas. Liver transplantation is the last resort in case of substantive concern about malignant transformation or for large, painful adenomas in liver cell adenomatosis after treatment attempts by liver resection.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Teslascan MRI at 24 hours after injection: uptake of contrast in left lobe and lateral aspect of right lobe by multiple adenomas (arrows).
See this image and copyright information in PMC

Comment in

References

    1. Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology. 1985;89(5):1132–8. - PubMed
    1. Wittekind C. Hermanek P, Gospodarowicz MK, Henson DE, et al. Springer; Berlin: 1995. Hepatocellular carcinoma and cholangiocarcinoma, Prognostic factors in cancer; pp. 88–93.
    1. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW. Epidemiology of hepatocellular adenoma—the role of oral contraceptive use. JAMA. 1979;242(7):644–8. - PubMed
    1. Heinemann LA, Weimann A, Gerken G, Thiel C, Schlaud M, Do Minh T. Modern oral contraceptive use and benign liver tumors: the German benign liver tumor-case control study. Eur J Contracept Reprod Health Care. 1998;3:194–200. - PubMed
    1. Edmondson HA. Tumors of the liver and intrahepatic bile ducts. Section 7, fascicle 25, Atlas of Tumor Pathology. Washington: Armed Forces Institute of Pathology; 1958.